Govt cuts GST on three cancer drugs
Patna: The state commercial taxes department on Wednesday notified the reduction of GST on three medicines—Tratstuzumab Daruxtecan, Onimartinib, and Durvalumab—used for the treatment of cancer, and also on extruded salty items. It also freed govt undertakings, research associations, colleges, and institutions that conduct research and development with govt or private grants under Section 36 of the IT Act, from the GST.